X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
index medicus (43) 43
male (30) 30
aged (25) 25
oncology (23) 23
middle aged (22) 22
human necessities (19) 19
hygiene (19) 19
medical or veterinary science (19) 19
preparations for medical, dental, or toilet purposes (19) 19
specific therapeutic activity of chemical compounds ormedicinal preparations (19) 19
prostate cancer (16) 16
urology & nephrology (16) 16
denosumab (13) 13
prostatic neoplasms - pathology (12) 12
urology (12) 12
abridged index medicus (11) 11
carcinoma (10) 10
female (9) 9
bone neoplasms - secondary (8) 8
double-blind method (8) 8
prognosis (8) 8
prostatic neoplasms - drug therapy (8) 8
research (8) 8
zoledronic acid (8) 8
aged, 80 and over (7) 7
antibodies, monoclonal, humanized (7) 7
health aspects (7) 7
medicine, general & internal (7) 7
article (6) 6
bone neoplasms - drug therapy (6) 6
cancer (6) 6
care and treatment (6) 6
metastasis (6) 6
prostatic neoplasms - surgery (6) 6
survival (6) 6
treatment outcome (6) 6
antibodies, monoclonal - therapeutic use (5) 5
bone density - drug effects (5) 5
breast-cancer (5) 5
cancer therapies (5) 5
diphosphonates - therapeutic use (5) 5
dna methylation (5) 5
drug therapy (5) 5
men (5) 5
polymerase-chain-reaction (5) 5
rank ligand - antagonists & inhibitors (5) 5
sensitivity and specificity (5) 5
adult (4) 4
androgen antagonists - therapeutic use (4) 4
antibodies, monoclonal - pharmacology (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
biomarkers, tumor - analysis (4) 4
bone density conservation agents - therapeutic use (4) 4
bone metastases (4) 4
breast cancer (4) 4
chemotherapy (4) 4
diagnosis (4) 4
disease-free survival (4) 4
dna (4) 4
dna, neoplasm - analysis (4) 4
dna, neoplasm - blood (4) 4
fractures (4) 4
glutathione transferase - genetics (4) 4
gstp1 gene (4) 4
imidazoles - therapeutic use (4) 4
internal medicine (4) 4
neoplasm staging (4) 4
osteoporosis (4) 4
polymerase chain reaction - methods (4) 4
promoter hypermethylation (4) 4
prostate-specific antigen - blood (4) 4
prostatic neoplasms - diagnosis (4) 4
prostatic neoplasms - genetics (4) 4
rank ligand - adverse effects (4) 4
rankl (4) 4
recurrence (4) 4
tumors (4) 4
analysis (3) 3
androgen antagonists - adverse effects (3) 3
androgens (3) 3
animals (3) 3
antibodies, monoclonal - adverse effects (3) 3
bone resorption (3) 3
cancer treatment (3) 3
complications (3) 3
disease (3) 3
drug administration schedule (3) 3
endocrinology & metabolism (3) 3
genetic aspects (3) 3
gleason score (3) 3
glutathione s-transferase pi (3) 3
gstp1 (3) 3
injections, subcutaneous (3) 3
k-ras mutations (3) 3
lung-cancer (3) 3
medical research (3) 3
medicine, research & experimental (3) 3
molecular diagnostic techniques (3) 3
multidisciplinary sciences (3) 3
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (107) 107
French (4) 4
Spanish (4) 4
Chinese (2) 2
German (1) 1
Icelandic (1) 1
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9768, pp. 813 - 822
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9810, pp. 39 - 46
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 18, pp. 1792 - 1793
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures. This placebo-controlled study... 
ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | FRACTURES | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 10/2011, Volume 8, Issue 10, pp. 625 - 625
Journal Article
The New England journal of medicine, 11/2017, Volume 377, Issue 18, p. 1792
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 18, pp. 1792 - 1793
To the Editor: In this trial involving women with metastatic breast cancer and a BRCA mutation, Robson et al. (Aug. 10 issue) 1 randomly assigned patients to... 
MEDICINE, GENERAL & INTERNAL | Phthalazines | Humans | Piperazines | Index Medicus | Abridged Index Medicus
Journal Article